Literature DB >> 1679230

Retinoblastoma cell lines Y79, RB355 and WERI-Rb27 are genetically related.

S A Madreperla1, R Bookstein, O W Jones, W H Lee.   

Abstract

Genesis of the childhood ocular tumor retinoblastoma results from the mutational inactivation of a single gene, RB, located on chromosome 13. Cultured cells or cell lines derived from retinoblastomas have been extensively studied for insight into mutational mechanisms of RB inactivation, functional properties of wild-type RB alleles, and pathways of retinal differentiation. Three such cell lines (Y79, RB355 and WERI-Rb27) were previously shown to have similar, heterozygous rearrangements of their RB genes, suggesting a common mutational mechanism affecting a specific region of the gene. This proposal was based on the premise that all three mutations occurred independently. By using molecular analyses of human genetic polymorphisms, we now show that these three cell lines are in fact genetically related, despite their different origins, morphologies, growth characteristics, and karyotypes. Interpretation of these and other published data suggest that both RB355 and WERI-Rb27 are probably sublines of Y79.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679230     DOI: 10.3109/13816819109023085

Source DB:  PubMed          Journal:  Ophthalmic Paediatr Genet        ISSN: 0167-6784


  7 in total

1.  Re-characterization of established human retinoblastoma cell lines.

Authors:  Maike Busch; Claudia Philippeit; Andreas Weise; Nicole Dünker
Journal:  Histochem Cell Biol       Date:  2014-10-19       Impact factor: 4.304

2.  Inhibition of Wnt/β-catenin by anthelmintic drug niclosamide effectively targets growth, survival, and angiogenesis of retinoblastoma.

Authors:  Zhi Li; Qin Li; Genguo Wang; Yi Huang; Xiaochun Mao; Yanfang Zhang; Xueyan Wang
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

3.  Crx activates opsin transcription by recruiting HAT-containing co-activators and promoting histone acetylation.

Authors:  Guang-Hua Peng; Shiming Chen
Journal:  Hum Mol Genet       Date:  2007-07-26       Impact factor: 6.150

4.  RB116: an RB1+ retinoblastoma cell line expressing primitive markers.

Authors:  Anthony Bejjani; Mee Rim Choi; Linda Cassidy; David W Collins; Joan M O'Brien; Tim Murray; Bruce R Ksander; Gail M Seigel
Journal:  Mol Vis       Date:  2012-11-29       Impact factor: 2.367

5.  Invasiveness and metastasis of retinoblastoma in an orthotopic zebrafish tumor model.

Authors:  Xiaoyun Chen; Jian Wang; Ziquan Cao; Kayoko Hosaka; Lasse Jensen; Huasheng Yang; Yuping Sun; Rujie Zhuang; Yizhi Liu; Yihai Cao
Journal:  Sci Rep       Date:  2015-07-14       Impact factor: 4.379

6.  mTOR inhibition by TAK-228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models.

Authors:  Lanlan Tang; Yu Fu; Jiarun Song; Taibing Hu; Kun Li; Zhi Li
Journal:  Pharmacol Res Perspect       Date:  2022-02

7.  Tigecycline as a dual inhibitor of retinoblastoma and angiogenesis via inducing mitochondrial dysfunctions and oxidative damage.

Authors:  Ying Xiong; Wei Liu; Qian Huang; Jierong Wang; Yanjun Wang; Huijuan Li; Xuedong Fu
Journal:  Sci Rep       Date:  2018-08-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.